CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Evive Biotechnology Shanghai's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 1, 2023Use Of Il-22 Dimer In Manufacture Of A Medicament For Intravenous Administration1
Jul 12, 2023Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease1